Home LiteratureArticle Details
PMID: 1732321 Published · ppublish English Clinical Trial Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis.

Journal of the American Academy of Dermatology ·Vol. 26 ·No. 1 ·1992-01-00 ·Pages 125-7

Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J

Abstract

暂无摘要

MeSH Terms
Administration, Topical Adult Allylamine/administration & dosage,adverse effects,analogs & derivatives Anti-Inflammatory Agents/administration & dosage,adverse effects Antifungal Agents/administration & dosage,adverse effects Betamethasone/administration & dosage,adverse effects,analogs & derivatives Clotrimazole/administration & dosage,adverse effects Double-Blind Method Drug Combinations Female Glucocorticoids Humans Male Ointments Tinea Pedis/drug therapy
Chemicals
Anti-Inflammatory Agents Antifungal Agents Drug Combinations Glucocorticoids Ointments Allylamine naftifine betamethasone-17,21-dipropionate Betamethasone Clotrimazole
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Smith E B
Department of Dermatology, University of Texas Medical Branch, Galveston.
Breneman D L
Griffith R F
Hebert A A
Hickman J G
Maloney J M
Millikan L E
Sulica V I
Dromgoole S H
Sefton J
Article Info
Journal
Journal of the American Academy of Dermatology
Abbr.
J Am Acad Dermatol
ISSN
0190-9622
Published
1992-01-00
Pages
125-7
Language
English
Region
United States
NLM ID
7907132
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]